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High Commitment of Embryonic Keratinocytes
to Terminal Differentiation
through a Notch1-caspase 3 Regulatory Mechanism
Introduction
Mouse skin provides an ideal model for studying the
coordinate control of epithelial cell growth and differen-
tiation, and for understanding how this balance is
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achieved during development. During embryogenesis,1Cutaneous Biology Research Center
complex and rapid developmental changes occur in theMassachusetts General Hospital and Harvard
skin that are required for the maturation of this organMedical School
and for adnexa formation (Hardy, 1992). Skin morpho-Charlestown, Massachusetts 02129
genesis is determined by a complex set of develop-2 Department of Dermatology
mental cues that act in a highly localized fashion toTohoku University Graduate School of Medicine
induce skin adnexa formation, while development andSendai, 980-8574
maturation of the interfollicular epidermis is thought toJapan
occur as a default pathway (Kopan and Fuchs, 1989).3 Laboratory of Cancer Pharmacogenomics
The most critical inductive signals leading to skin ad-Fondo “Edo Tempia”
nexa formation are acting before day E13.5/E14.513900 Biella
(McGowan and Coulombe, 1998). At later times of em-Italy
bryonal life, the skin, like other organs, undergoes a4 Ontario Cancer Institute
complex program of morphogenesis and massiveSt. Michael’s Hospital
expansion, suggesting that cells at this stage are en-Department of Medicine
dowed with a high growth/differentiation potential thatUniversity of Toronto
progressively decreases after birth. However, while theToronto, Ontario, M5G 2N9
high growth potential of mesenchymal cells of em-Canada
bryonal origin has been demonstrated, it has not been5 Department of Biochemistry
assessed whether this extends to epithelial cells, andLausanne University
to keratinocytes in particular.Epalinges 1066 CH
The Notch gene family encodes evolutionarily con-Switzerland
served transmembrane receptors with a key role in
cell-fate determination and differentiation (Artavanis-
Tsakonas et al., 1999). Notch activation is triggered by
interactions with ligands of the Delta and Serrate/Jag-Summary
ged families, and results in release of the intracellular
region of the receptor by proteolytic cleavage and nu-
Embryonic cells are expected to possess high growth/ clear translocation. The activated Notch intracellular
differentiation potential, required for organ morpho- region binds to a ubiquitous DNA binding protein of the
genesis and expansion during development. However, CSL family [Drosophila Suppressor of hairless (Su(H))
little is known about the intrinsic properties of embry- or its mammalian homolog RBP-J/CBF1], thereby con-
onic epithelial cells due to difficulties in their isolation verting it from a repressor into an activator of transcrip-
and cultivation. We report here that pure keratinocyte tion (Lai, 2002). This results in the induction of gene
populations from E15.5 mouse embryos commit irre- expression that affects differentiation in a cell type- and
versibly to differentiation much earlier than newborn context-dependent manner. Notch signaling is likely to
cells. Notch signaling, which promotes keratinocyte play a complex role in skin adnexa formation (Lin et
differentiation, is upregulated in embryonic keratino- al., 2000; Pourquie, 2000; Yamamoto et al., 2003, and
cyte and epidermis, and elevated caspase 3 expres- references therein). In the interfollicular epidermis,
sion, which we identify as a transcriptional Notch1 Notch1 activation is essential for promoting the exit of
target, accounts in part for the high commitment of keratinocytes from the cell cycle and entry into differen-
embryonic keratinocytes to terminal differentiation. In tiation (Lowell et al., 2000; Rangarajan et al., 2001; Nicko-
vivo, lack of caspase 3 results in increased prolifera- loff et al., 2002).
tion and decreased differentiation of interfollicular Recently, great interest has emerged for keratinocyte
stem cells, operationally defined as cells with highembryonic keratinocytes, together with decreased ac-
growth potential that are the likely targets for carcino-tivation of PKC-, a caspase 3 substrate which func-
genesis (Perez-Losada and Balmain, 2003). An attractivetions as a positive regulator of keratinocyte differentia-
hypothesis was that, like stem cells, embryonic keratino-tion. Thus, a Notch1-caspase 3 regulatory mechanism
cytes possess a high growth potential required for organunderlies the intrinsically high commitment of embry-
morphogenesis and expansion during development.onic keratinocytes to terminal differentiation.
However, little was known about the intrinsic growth/
differentiation properties of these cells due to difficulties
in their isolation and cultivation. Contrary to expecta-*Correspondence: gdotto@partners.org
tions, we report here that pure keratinocyte populations6 Present address: Lorantis Ltd 307 Cambridge, Science Park, Cam-
bridge, United Kingdom. from E15.5 mouse embryos have an intrinsically high
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Figure 1. Irreversible Commitment of Embry-
onic Keratinocytes to Differentiation
(A) Phase contrast photographs of primary
keratinocytes derived from E15.5 and new-
born mice which were cultured and main-
tained under low calcium conditions or
switched to high calcium medium for 1 or 6
days as indicated. Bar, 100 m.
(B) Crystal-violet-stained dishes of the same
cultures at the indicated times after calcium-
induced differentiation.
(C) Terminal differentiation marker expres-
sion in embryonic versus newborn mouse
keratinocytes as assessed by immunoblot-
ting with the corresponding antibodies. Total
cell extracts were prepared from keratino-
cytes under growing conditions and at vari-
ous times (hr) of calcium-induced differentia-
tion and analyzed for expression of Keratin 1
(K1), loricrin (Lor), and Keratin 5 (K5). The lat-
ter is constitutively expressed in cultured ker-
atinocytes irrespective of their growing ver-
sus differentiating conditions and was used
as equal loading control.
(D) Attachment efficiency of E15.5 (solid bars)
versus newborn (white bars) keratinocytes
which were freshly prepared and plated di-
rectly or kept in suspension for various
amounts of time (hr) prior to plating. Keratino-
cytes were plated onto collagen type IV-
coated dishes, and after 1 hr adherent cells
were fixed and stained with 0.1% crystal vio-
let. Staining intensity was determined with an
ELISA reader at 570 nm. Values are ex-
pressed as percentages relative to attached
cells that were plated immediately without
culture in suspension. Each point represents
the average of six different wells, and similar
results were obtained in a second indepen-
dent experiment.
(E) BrdU labeling index of E15.5 (solid bars) versus newborn (white bars) keratinocytes which attached to the dish after being kept into
suspension for the indicated amounts of time (hr). In all cases, cells were pulse labeled with BrdU for 3 hr at 36 hr after plating. The percentage
of BrdU-positive nuclei was determined in a minimum of six independent fields (100 cells/field), and the standard deviation among values
from the various fields was calculated. Values are expressed as percentages relative to BrdU labeling of cells that were plated immediately
without culture in suspension. Similar results were obtained in another independent experiment.
(F and G) Similar experiments as in (D) and (E), except that cells were kept in suspension either in the absence or presence of specific peptide
inhibitors for caspase 3 (DEVD-CHO) or caspase 1 (YVAD-CHO) activity.
commitment to terminal differentiation that can be ex- However, by 3–6 days, many of the embryonic cells
maintained in high calcium conditions sloughed off theplained, in part, by elevated Notch signaling and in-
creased caspase 3 expression, which we identify as a dish, while newborn cells remained attached and meta-
bolically active (Figures 1A and 1B). This was accompa-Notch transcriptional target.
nied by higher induction of loricrin, a terminal differentia-
tion marker of the outermost layers, in differentiatingResults
embryonic versus newborn keratinocytes, while expres-
sion of keratin 1, an “early” differentiation marker of theHigh Commitment of Embryonic Keratinocytes
to Terminal Differentiation intermediate layers, was lower in the embryonic cells
(Figure 1C). The increased susceptibility of embryonicTo assess the intrinsic growth/differentiation potential
of embryonic keratinocytes, we set up conditions for keratinocytes to terminal differentiation under these
conditions is not associated with enhanced apoptosisisolation and cultivation of these cells from E15.5 em-
bryos. Immunofluorescence analysis revealed that these as “classically” defined, as the number of cells positive
by TUNEL or Annexin V binding assays remained negligi-cultures contained 98% keratin-positive cells, with
similar morphology and proliferating fraction as kera- ble (Supplemental Figures S1A and S1B [http://www.
developmentalcell.com/cgi/content/full/6/4/551/DC1]).tinocytes from newborn mice (Figure 1A and data not
shown). Extracellular calcium concentration is an impor- To test whether the high propensity to terminally dif-
ferentiate is an intrinsic property of embryonic kera-tant determinant of keratinocyte growth and differentia-
tion (Hennings et al., 1980). At 1 day of high calcium tinocytes independent of their response to calcium, we
exploited the fact that maintaining keratinocytes in sus-exposure, embryonic keratinocytes underwent morpho-
logical changes like those of newborn cells (Figure 1A). pension provides an alternative means to induce late
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Figure 2. Elevated Notch Expression and Ac-
tivity in Embryonic versus Newborn Keratino-
cytes
(A) Immunostaining of embryonic and new-
born skin sections with antibodies against
the -secretase cleaved activated form of
Notch1. Bar: 15 m.
(B) Immunoblot analysis of freshly separated
epidermis from E15.5 and newborn mice with
antibodies against the indicated proteins.
One of these blots was stripped and reprobed
with antibodies against Ras-Gap as control
for equal loading conditions. The position for
molecular weight markers is indicated. Densi-
tometric quantification of the autoradio-
graphs coupled with normalization for levels
of ras-GAP expression indicated that relative
levels of total and activated Notch1 protein
were 3.3- and 13-fold higher, respectively, in
embryonic than newborn epidermis.
(C) Left panel: Measurements of endogenous
Notch activity by transient transfection of em-
bryonic (black bars) and newborn (white bars)
keratinocytes with a reporter for a Notch-
responsive promoter (HES-AB) or the pro-
moter with a small internal deletion which ab-
rogates Notch responsiveness (HES-AB).
Cells were transfected with the reporter pro-
moters together with pCDNA empty vector
or a vector for Notch1 antisense cDNA (AS-
Notch1). Cells were either kept under growing
low calcium conditions (0) or induced to dif-
ferentiate by calcium for the last 24 hr (24)
of the duration of the experiment (72 hr after
transfection). Right panel: similar assays of
E15.5 versus newborn keratinocytes tran-
siently transfected with reporter for minimal
c-Fos, TK, and SV40 promoters. Values are
expressed as folds of activation relative to
promoter activity in newborn keratinocytes
under low calcium conditions.
(D) Measurements of endogenous Notch ac-
tivity in embryonic keratinocytes as affected
by treatment with the -secretase inhibitor
DAPT. Cells were transiently transfected with
reporters for the Notch-responsive versus un-
responsive promoters (HES-AB and HES-
AB, respectively) and either treated (black bars) or untreated (white bars) with 1 M DAPT for 30 hr. Cells were maintained under growing
conditions or induced to differentiate by elevated calcium concentrations for the last 24 hr of the experiment.
(E) Immunoblot analysis of embryonic keratinocytes at the indicated times (hr) of high calcium exposure plus/minus DAPT treatment, with
antibodies against the terminal differentiation marker loricrin (Lor.) and keratin 5 (K5), which was used as equal loading control.
aspects of differentiation (Watt et al., 1988). Thus, uncul- capability of embryonic keratinocytes that attached to
the dish was progressively reduced when these cellstured keratinocyte preparations freshly derived from
embryonic and newborn mice were kept in suspension were kept into suspension for various times prior to
plating, while newborn keratinocytes showed little or nofor various times prior to plating. There was a drop in
plating efficiency of both embryonic and newborn kera- reduction (Figure 1E).
To confirm conclusions obtained with cultured cellstinocytes when these cells were kept in suspension for
1 hr rather than being plated immediately. However, in vivo, we examined the turnover of keratinocytes in
the intact skin. Females pregnant for 15.5 and 18.5 daysplating efficiency of newborn keratinocytes kept in sus-
pension for longer periods of time did not further de- and 2-day-old newborn mice were labeled by intraperi-
toneal injections with BrdU, and the BrdU labeling indexcrease, while that of embryonic cells was drastically
reduced (Figure 1D). The drop in plating efficiency of of epidermal cells in embryos and newborn mice was
evaluated 3 hr after injection, or 3 and 7 days later.embryonic keratinocytes was not accompanied by in-
creased apoptosis, as a similarly low fraction of TUNEL Previous reports indicated that proliferation occurs in
both basal and suprabasal epidermal layers of E15.5and Annexin V positive cells (3%–5%) was found with
both newborn and embryonic keratinocytes at all times embryos, while by day E18 it becomes limited to the
basal layer (see, for instance, Byrne et al., 1994). Afterof culture in suspension (Supplemental Figures S1C and
S1D). In parallel with these findings, the DNA synthesis 3 hr of labeling, the fraction of BrdU-positive cells in
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Table 1. Genes Concomitantly Upregulated in Embryonic Keratinocytes and in Response to Increased Notch1 Activity
Fold Upregulation
Gene ID Gene Name E15.5 Notch1 Function
Transcription control
L12703 Engrailed protein (En-1) 3.88 2.96 Homolog of Drosophila engrailed, homeobox gene.
U80078 Transcription factor BFCOL1 3.65 2.45 Kruppel family of zinc finger protein. Repression of the
transcription of gastrin, stromelysin, and enolase.
U81604 Eya3 homolog (Eya3) 3.64 2.35 Homolog of Drosophila eyes absent. Gene networks with
Pax, Six, and Dach.
Y10026 TEF4 2.89 7.66 Transcription factor expressed in preimplantation
embryos.
M18401 Homeobox 2.2 protein 2.86 2.08 Homeobox gene in specifying positional identity along the
anterior-posterior axis.
Y12783 Ring1B 2.83 2.05 Transcriptional repressor through interaction with
Polycomb proteins which suppress homeobox gene.
AF017806 Zn-15 transcription factor 2.78 2.18 Zinc finger factor activating transcription of growth
(Zfp-15) hormone.
X98207 Histone deacetylase 2.52 2.54 Controling transcriptional regulation and cell cycle
progression through acetylation state of histones.
X07439 Hox-3.1 2.50 2.63 Homeobox gene in specifying positional identity along the
anterior-posterior axis.
AI844532 Subunit of the splicing factor 2.49 2.56 Required for stable binding of U2 snRNP to breakpoint
SF3B sequence in pre-mRNA.
X13945 L-myc 2.18 3.18 A member of myc oncoprotein family binding to E-box
element of transcriptional targets.
D49654 Musashi-1 2.04 2.24 RNA-binding protein affecting cell-fate determination and
differentiation through translational repression.
Translation control
AJ243533 eIF2 kinase/GCN2 3.36 2.17 Regulating protein synthesis by phosphorylating the 
subunit of eukaryotic initiation factor (eIF2).
AA600468 Translational initiation factor 2 2.02 2.50 Initiation of protein synthesis.
 subunit
Intracellular signaling
U52193 Phosphoinositide 3-kinase 12.35 3.08 Phosphatidyl inositol (PtdIns) 3-kinase distinct from p110/
p85 and Vps34. Phosphorylating PtdIns.
U20159 76 kDa tyrosine 14.21 5.41 One substrate of T cell receptor activated tyrosine kinase
phosphoprotein SLP-76 pathway. Interacting with adaptor protein Grb2.
M80739 Protein tyrosine phosphatase, 2.27 2.21 Intracellular phosphotyrosine phosphatase expressed in
non-receptor type 2 various tissue.
Apoptosis
U54803 Caspase 3 2.84 3.46 Cysteine protease responsible for apoptosis execution.
Keratins
M22832 Keratin 18 4.56 26.12 Type I keratin intermediate filament protein expressed in
simple epithelia.
D89902 High-glycine tyrosine keratin 2.34 2.51 Type II high-glycine/tyrosine keratin chiefly expressed in
type II.4 hair cortical cells.
Transport/sorting
X75927 ABC transporter (ABC2 gene) 3.18 2.38 One of ATP binding cassette transporter family members
responsible for transport across cell membrane.
AF037312 Sulfonylurea receptor-1 2.56 2.61 Component of ATP-sensitive potassium channel.
(SUR-1)
AB026808 Synaptotagmin XI 2.22 2.48 Calcium sensor in the process of vesicular trafficking and
exocytosis.
Biosynthesis/metabolism
D26123 Carbonyl reductase 4.05 2.43 Enzyme to metabolize endogenous carbonyl compounds
such as aliphatic aldehydes and ketones.
AF031486 Spermidine 3.26 3.09 Biosynthesis of spermine from spermidine.
aminopropyltransferase
AB019541 -1,4-galactosyltransferase II 2.54 2.87 Synthesis of complex-type N-linked oligosaccharides in
glycoproteins and glyolipids.
L06047 Glutathione-S-transferase  1 6.94 2.85 Conjugation of reduced glutathione to hydrophobic
electrophiles.
U07159 Acetyl coenzyme A 4.29 2.34 Dehydrogenase in mitochondrial fatty acid -oxidation
dehydrogenase system.
Membrane proteins
U49185 Occludin 2.13 5.19 Integral membrane protein localizing at tight junction
regulating permeability barrier.
(continued)
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Table 1. Continued
Fold Upregulation
Gene ID Gene Name E15.5 Notch1 Function
Extracellular matrix
M15832 Procollagen, type IV, alpha 1 4.44 2.95 Major structural component of basement membrane
together with laminins, proteoglycans, and nidogen.
X13986 Minopontin 3.75 19.31 Binding to hydroxyapatite to form the mineralized matrix.
Ligand for integrin v3.
X70853 MB-90/fibulin C 2.86 3.16 Binding to laminin, nidogen, and collagenIV in calcium-
dependent manner.
PolyA	 RNA was prepared from uncultured keratinocytes freshly derived from E15.5 embryos and newborn (day 0) mice, and from primary
newborn keratinocyte cultures infected with an adenovirus-expressing GFP together with activated Notch1 (Ad-NIC) or only GFP (Ad-GFP).
cRNA probes from each condition were tested in duplicate by hybridization to Affymetrix U74A gene chips according to the manufacturer’s
recommendations. Only positive flurorescence intensity values above an arbitrary threshold of 300 and changes in gene expression of 2
folds in both duplicates of E15.5 versus newborn keratinocytes, and Notch1-expressing versus control cells, were considered as significant.
Shown are genes that could be assigned to a known or likely function, that were concomitantly upregulated in embryonic and Notch1-
expressing keratinocytes. Within each functional cluster, genes were ordered on the basis of their average folds of upregulation in embryonic
versus newborn cells. Besides caspase 3, increased expression of the En-1, Hox3.1, and Hox2.2 genes was also independently confirmed
by real-time PCR.
the basal layer of the E15.5 embryos was significantly Notch1 could also be detected in some cells of the
embryonic dermis but not the newborn.greater than in the E18.5 or newborn mice, as expected
for the elevated proliferative activity in the rapidly ex- For biochemical determinations, the epidermis of em-
bryonic and newborn skins was separated from the un-panding embryonic epidermis. Proliferation was also
readily detected in the suprabasal layer of the E15.5 but derlying dermis. Immunoblotting showed much higher
levels of activated Notch1 in embryonic versus newbornnot E18.5 or newborn epidermis (Supplemental Figure
S2). At 3 days after labeling, little or no BrdU-positive epidermis, which, by densitometric quantification of the
autoradiographs, could be explained only in part bycells were found in the basal layer of embryos labeled at
day E15.5, while an increased fraction of BrdU-positive higher total levels of the Notch1 protein in the embryonic
epidermis (Figure 2B). Jagged1, a Notch ligand whosecells was found in the suprabasal layers of these mice.
By contrast, a substantial number of BrdU-positive cells expression is positively regulated by activated Notch
(Luo et al., 1997), was also found at higher levels in theremained in the basal layer of mice labeled at the E18.5
and newborn stage, with BrdU-labeled cells becoming embryonic epidermis (Figure 2B). Amounts of the Notch2
protein, unlike Notch1, were similar in embryonic versusnow also present in the suprabasal layers (Supplemental
Figure S2). By 1 week after labeling, little or no labeled newborn epidermis (Figure 2B).
In parallel with the in vivo results, transient transfec-keratinocytes were found in the epidermis of mice de-
rived from the E15.5 BrdU-injected embryos in either tion of cultured cells with a reporter plasmid carrying a
Notch/RBP-J-responsive promoter (HES-AB) (Jarriaultbasal or suprabasal layers, while a substantial fraction
of labeled cells was still found in the epidermis of mice et al., 1995) showed several folds higher promoter activ-
ity in embryonic than newborn keratinocytes, especiallyderived from similarly labeled E18.5 embryos or new-
born (Supplemental Figure S2). Thus, while functional under differentiating conditions (Figure 2C). The ele-
vated activity of this promoter in embryonic cells wasturnover assays provide only an indirect indication of
the rate of differentiation, our findings are consistent substantially reduced by cotransfection of a Notch1
antisense cDNA, capable of suppressing to a significantwith E15.5 keratinocytes “transiting” at a faster rate to-
ward terminal differentiation even in the intact skin extent endogenous Notch signaling (Rangarajan et al.,
2001). In contrast to the HES-AB promoter, activitiesin vivo.
of the Notch-unresponsive HES-AB mutant promoter
(Jarriault et al., 1995) or unrelated promoters were similarElevated Notch1 Expression and Signaling
in Embryonic Keratinocytes in embryonic and newborn cells (Figure 2C, right panel).
Proteolytic cleavage by -secretase is required forNotch signaling plays a key role in promoting keratino-
cyte differentiation (Lowell et al., 2000; Nickoloff et al., activation of endogenous Notch receptors (Kopan and
Goate, 2000), and specific -secretase inhibitors such2002; Rangarajan et al., 2001). We hypothesized that
the intrinsically high commitment of embryonic keratino- as DAPT (N-(N-(3,5-difluorophenacetyl)-L-alanyl)-S-phe-
nylglycine t-butyl ester) have been used to suppresscytes to differentiation is linked to elevated Notch activ-
ity. Antibodies have been developed that are specific Notch activation (Yeh and Crews, 2003). Treatment of
embryonic keratinocytes with DAPT at IC50 concentra-for the -secretase cleaved activated form of Notch1
(Phiel et al., 2003). By immunohistochemistry, many cells tions (1 M) (Micchelli et al., 2003) was sufficient to
suppress activity of the Notch-responsive HES promoterstained positive for these antibodies already in the basal
layer of the embryonic epidermis, and more pronounced both under basal conditions and after induction of differ-
entiation, while activity of the mutated Notch-unrespon-staining was found in the suprabasal layers (Figure 2A).
By contrast, little or no signal was seen in newborn sive HES-AB promoter was unaffected (Figure 2D). In
parallel with this effect, DAPT treatment suppressed theepidermis. Interestingly, weak staining for activated
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Figure 3. Elevated caspase 3 Expression in Embryonic Keratinocytes and Skin and in Response to Notch1 Activation
(A) Immunoblot analysis with anti-caspase 3 antibodies of total cell extracts derived from embryonic (E) and newborn (N) keratinocytes under
low calcium conditions or treated with calcium for 24 hr, and of extracts of freshly separated embryonic and newborn epidermis. Arrows point
to the expected positions for caspase 3 in its precursor (32 kDa) and activated (17 kDa) forms. The same extracts were analyzed for levels
of caspase 14 expression by immunoblotting with the corresponding antibodies. Reprobing of the immunoblots with antibodies against Ras
GAP was used as control for equal loading conditions.
(B) Immunoblot analysis with anti-caspase 3 antibodies of total cell extracts derived from newborn keratinocytes infected with a recombinant
adenovirus expressing activated Notch1 (N1) or with an Ad-GFP control (G) at the indicated times after infection (hr). Immunoblotting with
anti-Ras GAP antibodies was used as control for equal loading conditions. Un., uninfected control cells.
(C and D) Immunohistochemical analysis of the epidermis of E15.5 embryos and newborn mice with antibodies specific for caspase 3 or its
activated form. Bars: 30 m.
(E) Induction of caspase 3 promoter activity by activated Notch1. Newborn keratinocytes under basal growing conditions were transfected
with a luciferase reporter plasmid for the mouse caspase 3 promoter plus/minus an expression vector of the activated form of Notch1 in
increasing amounts.
(F) Induction of caspase 3 promoter activity by Notch1 through a RBP-J-dependent mechanism. Newborn keratinocytes were transfected
with the caspase 3 promoter reporter together with a vector for activated Notch1ICN plus/minus increasing amounts of a vector for dominant-
negative RBP-J (dnRBP).
(G) Increased Notch/RBP-dependent activity of the endogenous caspase 3 promoter activity in embryonic keratinocytes. Parallel cultures of
E15.5 (solid bars) and newborn (white bars) keratinocytes under basal growing conditions were transiently transfected with the caspase 3
promoter luc reporter together with a TK-renilla reporter for internal normalization, plus/minus the addition of expression vector for dominant-
negative RBP-J.
induction of the loricrin marker in differentiating embry- 1994). Expression of some of these mediators may be
selectively elevated in embryonic keratinocytes, as aonic keratinocytes (Figure 2E).
reflection of increased Notch activity. We investigated
this possibility by global analysis of gene expression,Upregulation of caspase 3, a Notch1
Transcriptional Target, in by oligonucleotide array hybridization. We found that
15% of genes with2-fold higher expression in uncul-Embryonic Keratinocytes
Terminal differentiation of keratinocytes can be viewed tured embryonic versus newborn keratinocytes (ob-
tained from freshly separated epidermis) were also in-as a specialized form of programmed cell death, and
may rely on some of the same mediators as classical duced in newborn keratinocytes in response to activated
Notch1 expression (Table 1). Among the genes thatapoptosis (Maruoka et al., 1997; Polakowska et al.,
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could be assigned to known functions, there were sev- of this protein and its activated form was strongly de-
eral involved in transcription and translation control, sig- creased in the DAPT-treated skin (Figure 4B), in parallel
nal transduction, intermediate metabolic pathways, cell with an increase in epidermal thickness (Figure 4C),
structure, and adhesion. Only one gene involved in pro- which is similar to that observed with the skins of cas-
grammed cell death was found: caspase 3. pase 3
/
 embryos (as described further below).
Immunoblot analysis confirmed that caspase 3 is ex-
pressed at higher levels in embryonic than newborn Involvement of caspase 3 in Embryonic
keratinocytes, both in culture and the intact epidermis Keratinocyte Growth/Differentiation Control
(Figures 3A and 3C), and that its expression is induced To assess whether elevated caspase 3 expression and
in newborn keratinocytes by activated Notch1 (Figure activity contribute to the increased commitment of em-
3B). Moreover, embryonic but not newborn keratino- bryonic keratinocytes to terminal differentiation, fresh
cytes contained also detectable amounts of the 17 kDa keratinocyte preparations from embryonic mice were
caspase 3 activated form (Figure 3A). Consistent with placed in suspension in the presence or absence of a
these results, immunohistochemical analysis with anti- caspase 3 peptide inhibitor (DEVD-CHO) or a similar
bodies specific for the active form of caspase 3 pro- inhibitor specific for caspase 1 (YVAD-CHO) (Nicholson
duced a much stronger positive staining in the embry- et al., 1995; Schlegel et al., 1996). As shown in Figure
onic than newborn epidermis (Figure 3D). 1F, treatment with the caspase 3 inhibitor could partially
Caspase 14 has been recently connected with kera- circumvent the drop in plating efficiency of embryonic
tinocyte differentiation control in the mature skin (Lip- keratinocytes, especially at early times of suspension
pens et al., 2000). Microarray analysis indicated that culture, while treatment with the caspase 1 inhibitor had
expression of this gene, like those for other components no such effect. Concomitantly, the caspase 3 inhibitor
of the apoptotic apparatus, is not increased in the em- restored to a substantial degree the DNA synthesis ca-
bryonic keratinocytes. Direct immunoblot analysis con- pability of the embryonic cells that attached to the dish
firmed that caspase 14, unlike caspase 3, is expressed after being kept into suspension for various times, while
at similar levels in embryonic and newborn keratino- this did not occur with the caspase 1 inhibitor (Figure
cytes, and a cleaved activated form of caspase 14 was 1G). Protective effects similar to those of the caspase
found in the intact epidermis of newborn mice but not 3-specific inhibitor were exerted by broader-specificity
of embryos (Figure 3A). caspase inhibitors such as Z-VAD-FMK and Boc-D-FMK
To further verify that caspase 3 expression is under (Supplemental Figure S3). Parallel experiments with
Notch control, we cloned the mouse caspase 3 promoter newborn keratinocytes showed no effects on plating
region into a luciferase reporter plasmid. Caspase 3 efficiency or DNA synthesis by caspase 3 or caspase 1
promoter activity was substantially induced in newborn inhibitors (data not shown).
keratinocytes by coexpression of either activated To assess the role of caspase 3 in the balance be-
Notch1 or Notch2, such induction being counteracted tween keratinocyte growth and differentiation in vivo,
by the concomitant expression of a dominant-negative we examined the skin of mice with a null mutation of
RBP-Jmutant (Figures 3E and 3F and data not shown).
the caspase 3 gene (Woo et al., 1998). These mice have
In embryonic keratinocytes, basal activity of the caspase
an abnormal brain development due to defective apo-
3 promoter was significantly higher than in the newborn
ptosis and a fraction of them dies around birth (Kuida
cells, using a minimal TK promoter as internal normaliza-
et al., 1996; Woo et al., 1998). Histological analysis re-tion control, and such elevated activity in embryonic
vealed a consistent increase (30%; n 9) in epidermalkeratinocytes was suppressed in a dose-dependent
thickness of caspase 3
/
 embryos (E15.5) relative tomanner by cotransfection with a vector for a dominant-
heterozygous and wild-type controls. The fraction ofnegative RBP-J mutant (Figure 3G).
proliferating keratinocytes was 2-fold higher in theConventional disruption of the Notch1 gene results in
knockout skin than controls (Figure 5A). Conversely, ex-embryonic lethality at E9.5 days (Conlon et al., 1995;
pression of terminal differentiation markers loricrin andSwiatek et al., 1994). The Notch1 gene flanked by loxP
filaggrin was strongly reduced in the caspase 3
/
 epi-sites can be efficiently deleted by induction of Cre re-
dermis, while expression of keratin 1, an “early” markercombinase activity in the skin of mice only after birth
of the spinous layer, was comparable to controls (Figure(Rangarajan et al., 2001). As an alternative approach to
5B). At birth, the fraction of proliferating keratinocytessuppress Notch function during embryonic develop-
was also 2-fold higher in the epidermis of caspase 3
/
ment, we resorted to the -secretase inhibitor DAPT
versus wild-type or heterozygous mice, while expres-(Dovey et al., 2001). Loss of -secretase activity by gene
sion of terminal differentiation markers was by this timeablation experiments results in a phenotype strikingly
normalized (data not shown).similar to that of Notch deletion in both Drosophila and
Caspase 3 has many possible substrates (as reviewedmice (Kopan and Goate, 2000), and inhibition of enzy-
in Fischer et al., 2003). Among these, the protein kinasematic activity by DAPT causes a similar phenotype (Mic-
C  isoform is an important inducer of keratinocyte differ-chelli et al., 2003). Skin organ cultures were established
entiation (Ohba et al., 1998; Tibudan et al., 2002) and isfrom E13.5 embryos and incubated in the presence or
subject to direct activation by caspase 3 cleavage (Em-absence of DAPT at IC50 concentration for 48 hr. Immu-
oto et al., 1995; Ghayur et al., 1996). Immunoblottingnohistochemical analysis with antibodies against total
with antibodies against the activated phosphorylatedversus activated Notch1 indicated that the DAPT treat-
form of PKC- (Emoto et al., 1995) revealed that acti-ment caused the expected suppression of Notch1 acti-
vated PKC-, intact as well as cleaved product retainingvation in cultured embryonic skins (Figure 4A). Staining
with anti-caspase 3 antibodies showed that expression the recognized auto-phosphorylation site, is present at
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Figure 4. Suppression of Endogenous Notch Activity in Embryonic Skin Organ Cultures by -Secretase Inhibition
Dorsal back skins from E13.5 mouse embryos were cultured for 48 hr in medium with the -secretase inhibitor DAPT (1 M) or DMSO vehicle
alone. (A, B, and D) Skins were then processed for immunohistochemical analysis with antibodies against the indicated proteins. Similar
immunostaining results were obtained with four independent skin cultures treated with DAPT versus four controls. (C) The epidermal thickness
of the cultured skins was quantified by a computer-assisted analysis of digitally acquired images of a minimum of ten independent areas per
section. Standard deviation of measurements is indicated.
higher levels in embryonic than newborn keratinocytes, embryonic epithelial cells, little or no information is avail-
especially upon induction of differentiation (Figure 6A). able on their intrinsic growth/differentiation properties.
Total PKC- amounts were similar in all cases. Poly Contrary to what was expected for cells of an organ
(ADP-ribose) polymerase (PARP) is another main cleav- undergoing rapid morphogenesis and expansion, we
age target of caspase 3, as well as other caspases, have found that keratinocytes from E15.5 mouse em-
during classical apoptosis (Fischer et al., 2003). Immu- bryos have an intrinsically high propensity to terminally
noblot analysis showed that there was no detectable differentiate. This property can be explained, in part,
PARP cleavage in differentiating embryonic or newborn by elevated Notch signaling and increased caspase 3
keratinocytes, while total levels of this protein de- expression, which we have identified as a transcriptional
creased with differentiation to a similar extent in both target of Notch activation.
types of cells (Figure 6B). A global analysis of gene expression indicated that a
Consistent with the immmunoblotting results, immu- substantial fraction of genes that are upregulated in
nohistochemistry with the phospho-specific PKC- anti- embryonic versus newborn keratinocytes are also posi-
bodies produced a much stronger signal in keratino- tively controlled by Notch1 activation. Among these
cytes of embryonic than newborn skin (Figure 6C), and genes there were transcription factors with a known role
the staining was much higher in the skin of wild-type in development and cell fate determination, such as
versus caspase 3 knockout embryos (Figure 6D). Finally, En-1, Hox3.1, and Hox2.2 (Cillo et al., 2001). The func-
staining with the phospho-specific PKC- antibodies tional significance of upregulation of these genes is be-
was also substantially reduced in cultured embryonic ing explored. Here we focused on caspase 3, the only
skins treated with the DAPT -secretase inhibitor (Figure gene involved in programmed cell death that was found
4D), consistent with PKC- activation, like elevated cas- to be concomitantly upregulated in embryonic keratino-
pase 3 expression, being dependent on endogenous cytes and in response to Notch1.
Notch activity. Caspase 3 is a main effector of both death receptor-
and mitochondria-dependent apoptosis (Earnshaw et
al., 1999). Most work has focused on regulation of cas-Discussion
pase 3 activity at the posttranscriptional level. However,
the caspase 3 gene has also been reported to be differ-Genetic analysis of mouse models as well as direct in
entially expressed in various tissues and developmentalvivo manipulation experiments have provided significant
times as well as during neuronal apoptosis triggered byinsights into signaling pathways involved in organ devel-
opment and morphogenesis. However, with regard to various stimuli (Earnshaw et al., 1999). The basis for
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Figure 5. Perturbed Growth/Differentiation
Balance of Keratinocytes in Embryonic Skin
by Disruption of the caspase 3 Gene
(A) E15.5 embryos carrying a homozygous
disruption of the caspase 3 gene (Woo et al.,
1998) were analyzed in parallel with heterozy-
gous littermates and wild-type control, by H/E
staining or immunofluorescence analysis of
their epidermis with antibodies against Ki67,
a maker of cell proliferation. Bar: 20 m.
Same regions of mouse back skin were ana-
lyzed in each case. The percentage of Ki67-
positive cells was determined in two animals
for each genotype, counting, in each case, at
least eight independent fields. The standard
deviation from the various fields is indicated.
(B) Frozen skin sections from E15.5 embryos
with a deletion of the caspase 3 gene and
wild-type controls (	/	) were analyzed by
immunofluorescence with polyclonal anti-
bodies against the keratin 1 (K1), loricrin (Lor),
and filaggrin (Fil) differentiation markers.
Identical exposure and image capture condi-
tions were used for comparison of the cas-
pase 3	/	 and caspase 3
/
 skins. Bar: 30 m.
transcriptional regulation of this gene remains to be elu- restricted requirement for apoptosis of other cell types,
such thymocytes or hepatocytes (Kuida et al., 1996;cidated. Our findings indicate that expression of the
endogenous caspase 3 gene, as well as transcriptional Woo et al., 1998; Zheng et al., 1998). A possible role of
caspase 3 beyond classical apoptosis in differentiationactivity of its promoter, is enhanced in embryonic kera-
tinocytes in a Notch-dependent manner and that the of several cell types is currently emerging (De Maria et
al., 1999; Fernando et al., 2002; Ishizaki et al., 1998;caspase 3 gene is an upregulated target of Notch1 and
Notch2 activation. The elevated levels of endogenous Sordet et al., 2002; Zermati et al., 2001). An involvement
of caspase 3 in keratinocyte differentiation control wasNotch activity in embryonic keratinocytes were not af-
fected by caspase 3 inhibition, indicating that, while previously suggested by pharmacological studies of hu-
man keratinocytes in organotypic cultures (Weil et al.,controlled by Notch, caspase 3 in turn does not regulate
Notch activation. The rat and human caspase 3 promoter 1999). This possibility was later questioned by the fact
that no caspase 3 activation was found in differentiatingregions have been recently characterized and found to
contain several responsive elements for ubiquitous tran- mouse or human epidermal cells derived from newborn
or adult skin (Lippens et al., 2000). This is consistentscription factors such as Sp1 and Ets-1 (Liu et al., 2002),
which are fully conserved in the mouse promoter (our with the fact that, in parallel with increased expression,
we could detect caspase 3 activation only in embryonalunpublished data). This region of the caspase 3 pro-
moter contains also potential binding sites for RBP-J keratinocytes and skin but not in the newborn.
Disruption of the caspase 3 gene causes no evidentthat do not have, however, a fully conserved consensus
sequence. Further biochemical approaches will be re- defects in hair follicle development and hair cycle distri-
bution, which depend, to a large extent, on classicalquired to establish whether, while RBP-J-dependent,
upregulation of caspase 3 by Notch1/2 activation in- apoptosis (Hardy, 1992). Rather, our analysis shows that
caspase 3 plays an important role in the balance be-volves direct binding of RBP-J to the caspase 3 pro-
moter or more indirect mechanisms. tween growth and differentiation of interfollicular kera-
tinocytes during late stages of embryonic development.Gene ablation experiments have revealed that cas-
pase 3 plays a critical role during embryonic develop- In the embryonic epidermis, in spite of the widespread
expression and activation of caspase 3, the number ofment in apoptosis of neurons in the brain, with a more
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Figure 6. Elevated Levels of Activated PKC-
in Embryonic Keratinocytes and Skin, Depen-
dent on caspase 3 Function
(A) Total cell extracts from embryonic and
newborn keratinocytes under growing con-
ditions (0) and at various times (hr) of cal-
cium-induced differentiation were analyzed
by immunoblotting with antibodies against
the activated phosphorylated form of PKC-
(upper panel) or antibodies recognizing the
total protein (lower panel).
(B) Total cell extracts from embryonic and
newborn keratinocytes under growing condi-
tions (0) and at various times (hr) of calcium-
induced differentiation were analyzed by im-
munoblotting with antibodies against poly
(ADP-ribose) polymerase (PARP). PARP is a
116 kDa nuclear protein that is converted by
caspase cleavage during apoptosis into a 89
kDa C-terminal catalytic domain and a 24 kDa
N-terminal DNA binding domain. Arrows
point to the 116 kDa full-length protein and
the expected position for the 89 kDa cleav-
age product.
(C) Frozen skin sections from E15.5 embryos
and newborn mice were analyzed by immu-
nostaining with antibodies against the acti-
vated phosphorylated form of PKC- (upper
panel) or antibodies recognizing the total pro-
tein (lower panel).
(D) Frozen skin sections from wild-type (	/	)
and caspase 3 negative (
/
) embryos
(E15.5) were analyzed by immunostaining
with antibodies against the activated phos-
phorylated form of PKC- (upper panel) or
antibodies recognizing the total protein
(lower panel). Bar: 30 m.
cells undergoing classical apoptosis is as low as after activity. Consistent with this possibility, the observed
increase in caspase 3 expression is accompanied bybirth. This suggests that elevated caspase 3 levels in
these cells are not sufficient to trigger apoptosis but production of the caspase 3 activated form as well as
phospho-PKC-. In addition, levels of phospho-PKC-result in the more selective targeting of substrates that
are involved in the keratinocyte differentiation process, and induction of differentiation marker expression in
newborn keratinocytes expressing activated Notch1 areincluding, as we have shown, activation of PKC-. In
fact, caspase 3 is selectively required in the embryonic significantly suppressed by inhibition of caspase 3 activ-
ity (Supplemental Figure S4). Further analysis of theepidermis for elevated expression of the “late” terminal
differentiation markers of the outermost layers, but not involvement of caspase 3 in the response of mature
keratinocytes to Notch activation will be the topic offor expression of the “early” markers of the intermediate
layers. This specificity of function is in agreement with future studies.
The surprisingly high commitment to terminal differen-the substantially higher levels of “late” but not “early”
markers in wild-type embryonic versus newborn kera- tiation of embryonic keratinocytes coincides with a cru-
cial time in embryonic skin development when matura-tinocytes, and the fact that only the “late” markers are
induced by PKC activation while the “early” ones are tion of this organ is being established (Hardman et al.,
1998). The somewhat counterintuitive conclusion thatreduced (Dlugosz and Yuspa, 1993).
While in newborn keratinocytes expression of cas- embryonic epidermal cells have a higher commitment
to differentiation than cells at more mature stages maypase 3 is usually low, its induction in response to acti-
vated Notch1 suggests that caspase 3 could also con- apply to other epithelial tissues as well. This has impor-
tant implications for the possible utilization of embryonictribute to the response of these cells to elevated Notch1
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